Hemp Startup Founders Accused of Stock Fraud

The two co-founders of CanaFarma Hemp Products have been billed with fraudulently raising $fifteen million from investors by making fake statements about the “farm to table” hemp startup and its management.

The U.S. Securities and Exchange Fee said Vitaly Fargesen and Igor Palatnik misrepresented CanaFarma as a “fully integrated” hemp company and inflated its income in resources for two non-public choices of shares whilst pocketing $4 million of the trader funds for their personalized use and needs unrelated to CanaFarma.

They also touted the good quality of CanaFarma’s management group, which was purportedly led by CEO David Lonsdale when, in reality, he “was CEO in identify only, making no substantive conclusions and using course from Fargesen and Palatnik,” the SEC said in a civil grievance.

Fargesen and Palatnik have also been indicted on relevant felony fraud prices.

“Fargesen and Palatnik had been just utilizing the trappings of a startup to operate an old-time scam: lying to investors to choose revenue for on their own,” Manhattan U.S. Attorney Audrey Strauss said in a information launch.

In accordance to the SEC, CanaFarma’s stated business enterprise program was increase hemp at two farms in New York and process it into hemp goods this sort of as “Yooforic” chewing gum that it would sector instantly to consumers. Lonsdale, the president of boutique finance company Lonsdale Team, was hired in March 2019.

Fargesen and Palatnik, who had been vice presidents of the company on paper, “told [Lonsdale] and other individuals at CanaFarma that [he] would act as a mere figurehead CEO and would not make any precise conclusions,” the SEC said.

CanaFarma, having said that, allegedly did not manufacture Yooforic alone, licensing production to a third bash and leaving the hemp it grew in storage, unused. “Fargesen informed an person … that CanaFarma was making payments to the very first hemp farm ‘just for the story,’” according to the SEC.

For its second featuring, the company claimed that in March 2020, it was “achieving just about $one,000,000 for every thirty day period revenue” but achieved “only roughly $44,000 in income in March 2020” and “never achieved $one million in regular revenue” whilst it was conducting the fund raises.

Tafadzwa Ufumeli by using Getty Illustrations or photos

CanaFarma Hemp Products, David Lonsdale, hemp, Igor Palatnik, U.S. Securities and Exchange Fee, Vitaly Fargesen